Projects IrsiCaixa is involved in a hundred national and international research projects active each year, funded by both public and private entities. Breadcrumb Home Projects Keywords Research group - Any -Cell Virology and Immunology (VIC)HIV and HVC Genetic and Phenotypic VariabilityHost Genetics and Cellular ImmunityImmunology (IGG)Microbial Genomics (GEM)Neoantigens and Vaccines for Cancer (NeoVaCan)Pathogen Immunity, Signalling and Therapeutic Applications (PISTA)Retrovirology and Clinical Studies (GREC)Tissue Virology (VITI)Translational Research in Immunology and Ageing (TRIA)Viral Immune Evasion and Vaccines (VIRIEVAC)Virus-Host Interactions (ViHIT) Researcher - Any -Aleix Elizalde TorrentAlejandro Riquelme GrauAlessandra BorgognoneAlex Olvera van der StoepAna Barajas MolinaAnaí Villanueva DelgadoAnna López PlanaAnna Pons GrifolsArnau Creus OrodeaBeatriz Mothe PujadasBenjamin TrinitéBonaventura Clotet SalaCarla Rovirosa MartíCarlos Blázquez BondiaCarlos Ávila NietoCarmen Aguilar GurrieriCecilia Cabrera NavarroChristian BranderClara Duran CastellsCristina Mesa RealCristina Peligero CruzCristina Ramírez SotoDaniela Benítez CanoDaniel Pérez ZsoltDàlia Raïch ReguéEdurne García VidalEdwards Pradenas SaavedraElena Lapaz LorenzoElisabet Fernández RosasElisabet García RodríguezElisa Molina MolinaErola Ainsua EnrichEster Ballana GuixEudald Felip FalgàsEudald Vehí PiquéEulalia Grau SegúEva Riveira MuñozFernando Laguía NuedaFerran Abancó i EspugaFrancesc Català MollFrancisco M. Muñoz LópezGabriel Felipe Rodríguez LozanoGerard Campos GonzalezGisela Zamorano GarcíaGustavo Rodríguez EstebanIgnasi Calba IñiguezIgor Moraes CardosoIrene González NavarroItziar Erkizia JauregiJakub ChojnackiJavier Martínez-PicadoJon Izquierdo PujolJordi Senserrich VelascoJorge Carrillo MolinaJosé Luis Pérez GuillamónJudith Dalmau MorenoJulia García PradoJulieta CarabelliJulià Blanco ArbuésJulián Eslava CampoJúlia Albó DelgadoLaia Bernad RosaLaia Vives AdriánLaura Planells FerrerLidia Garrido SanzLidia Ruiz TabuencaLluís Revilla SanchoLourdes Grau ParéLucía Gutiérrez ChamorroLucía Gómez EspadaMacedonia Trigueros PeñaManel Garcia de la FuenteMarc Noguera i JulianMaria Casadellà FontdevilaMaria Nevot BanúsMaria Salgado BernalMarina Pino CebriánMariona Parera SallentMarissa Flores SantamaríaMarta Massanella LunaMarta Navarro GutiérrezMarta Ruiz RiolMaría Lázaro DíezMiguel Marín LópezMiguel Ángel Martínez de la SierraMireia Martínez GameroMª Carmen García GuerreroMª Carmen Puertas CastroMª Luisa Rodríguez de la ConcepciónNatàlia Marrugat VilaNuria Izquierdo UserosNúria de la Iglesia ZaragozaNúria Pedreño LópezPatricia Resa InfantePenélope Riquelme NevadoPep Coll VerdRafaela Ayen AparicioRaúl Pérez CaballeroRita Casas CostaRoger Badia CórcolesRoger ParedesRosina Malagrida EscalaRuth Peña PoderósRytis BoreikaSamandhy Cedeño BriceñoSandra Franco CireraSandra Silva ArrietaSara Morón LópezSilvia Marfil VerchiliSonia Bange SinghSusana Esteban RayaTeresa Puig OlivaTetyana PidkovaToni Navarro AlcarazTuixent Escribà BelValentina Triviño VenceVíctor Urrea GalesÁngel Bayón Gil From date To date Role of NK cells in post COVID-19 condition (LoNK-COVID) Project status Ongoing Start/End 2022 / 2025 Principal investigator Maria Nevot Banús Strategic lines Immunopathology Financing entity Ministerio de Ciencia e Innovación (PID2021-124226OB-I00) The epigenetic cascade of neurotropic viral infections (NEUROEpiCas) Project status Ongoing Start/End 2021 / 2024 Principal investigator Christian Brander Strategic lines Immunopathology Financing entity Ministerio de Ciencia, Innovación y Universidades (MICINN) Code: PID2020-119710RB-I00 Ageing with HIV: the role of metabolism in HIV persistence and pronounced immune ageing Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Massanella Luna Participating entities IrsiCaixa, FLS Strategic lines Immunopathology Financing entity ISCIII Boosted Flow Cytometry as a Diagnostic and Monitoring Tool for Virus/Pathogen specific T-Cell immune Profiles in HIV, TB and COVID Diseases Project status Ongoing Start/End 2022 / 2024 Principal investigator Marta Ruiz Riol Strategic lines Cancer Emerging infectious diseases Global infectious diseases Financing entity “la Caixa” Banking Foundation Code: CI21-00100 New antiviral and immunomodulatory therapies against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity Spanish Ministry of Science and Innovation Immune strategies against HIV persistence Project status Ongoing Start/End Principal investigator Bonaventura Clotet Sala Financing entity Ministerio de Ciencia Innovación y Universidades. Instituto de Salud Carlos III RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Clara Duran Castells Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118 Assessment of the antiviral activity against SARS-CoV-2 of certain mouthwashes Project status Ongoing Start/End 2021 / 2022 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity DENTAID S.L. Engineered enveloped VLP’s with high-density antigen coating. A proof of concept for their application in animal health. FeLV vaccines Project status Ongoing Start/End 2021 / 2022 Principal investigator Julià Blanco Arbués Strategic lines Cancer Emerging infectious diseases Financing entity HIPRA Scientific Identification and Validation of Early Biomarkers of Acute COVID-19 to Predict Evolution. IVETTE Project status Ongoing Start/End 2021 / 2024 Principal investigator Bonaventura Clotet Sala Julià Blanco Arbués Financing entity Fundació "la Marató de TV3" Code: 202113-31 Pagination 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next Last
Role of NK cells in post COVID-19 condition (LoNK-COVID) Project status Ongoing Start/End 2022 / 2025 Principal investigator Maria Nevot Banús Strategic lines Immunopathology Financing entity Ministerio de Ciencia e Innovación (PID2021-124226OB-I00)
The epigenetic cascade of neurotropic viral infections (NEUROEpiCas) Project status Ongoing Start/End 2021 / 2024 Principal investigator Christian Brander Strategic lines Immunopathology Financing entity Ministerio de Ciencia, Innovación y Universidades (MICINN) Code: PID2020-119710RB-I00
Ageing with HIV: the role of metabolism in HIV persistence and pronounced immune ageing Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Massanella Luna Participating entities IrsiCaixa, FLS Strategic lines Immunopathology Financing entity ISCIII
Boosted Flow Cytometry as a Diagnostic and Monitoring Tool for Virus/Pathogen specific T-Cell immune Profiles in HIV, TB and COVID Diseases Project status Ongoing Start/End 2022 / 2024 Principal investigator Marta Ruiz Riol Strategic lines Cancer Emerging infectious diseases Global infectious diseases Financing entity “la Caixa” Banking Foundation Code: CI21-00100
New antiviral and immunomodulatory therapies against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity Spanish Ministry of Science and Innovation
Immune strategies against HIV persistence Project status Ongoing Start/End Principal investigator Bonaventura Clotet Sala Financing entity Ministerio de Ciencia Innovación y Universidades. Instituto de Salud Carlos III
RBD Dimer recombinant protein vaccine against SARS-CoV-2 Project status Ongoing Start/End 2021 / 2024 Principal investigator Marta Ruiz Riol Julià Blanco Arbués Christian Brander Clara Duran Castells Jorge Carrillo Molina Samandhy Cedeño Briceño Julia García Prado Nuria Izquierdo Useros Tuixent Escribà Bel Eulalia Grau Segú Beatriz Mothe Pujadas Strategic lines Cancer Emerging infectious diseases Financing entity European Commission Codi: 101046118
Assessment of the antiviral activity against SARS-CoV-2 of certain mouthwashes Project status Ongoing Start/End 2021 / 2022 Principal investigator Nuria Izquierdo Useros Participating entities IrsiCaixa Strategic lines Cancer Emerging infectious diseases Financing entity DENTAID S.L.
Engineered enveloped VLP’s with high-density antigen coating. A proof of concept for their application in animal health. FeLV vaccines Project status Ongoing Start/End 2021 / 2022 Principal investigator Julià Blanco Arbués Strategic lines Cancer Emerging infectious diseases Financing entity HIPRA Scientific
Identification and Validation of Early Biomarkers of Acute COVID-19 to Predict Evolution. IVETTE Project status Ongoing Start/End 2021 / 2024 Principal investigator Bonaventura Clotet Sala Julià Blanco Arbués Financing entity Fundació "la Marató de TV3" Code: 202113-31